Wei Guo

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 21

Top Venues

Thoracic cancer

NPJ precision oncology

Cancer medicine

Nature communications

Chinese Academy of Medical Sciences Cancer Institute and Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Chinese Academy of Medical Sciences Cancer Institute and Hospital Aug 01 2016

China

Resident :: Thoracic surgery

Publications

Bolun Zhou, Fan Zhang, Wei Guo, Shuhang Wang, Ning Li, Bin Qiu, Liang Zhao, Jian Li, Kang Shao, Qi Xue, Fang Lv, Shugeng Gao
Five-year follow-up of neoadjuvant PD-1 inhibitor (sintilimab) in non-small cell lung cancer. Journal for immunotherapy of cancer 12 (8) (2024)
Wei Guo, Tan Wang, Qilin Huai, Lei Guo, Xiaobing Wang, Jie He
KIAA1429 regulates lung adenocarcinoma proliferation and metastasis through the PI3K/AKT pathway by modulating ARHGAP30 expression. Thoracic cancer (2024)
Li Sun, Wei Guo, Lei Guo, Xiaoxi Chen, Haitao Zhou, Shi Yan, Gang Zhao, Hua Bao, Xue Wu, Yang Shao, Jian-Ming Ying, Lin Lin
Molecular landscape and multi-omic measurements of heterogeneity in fetal adenocarcinoma of the lung. NPJ precision oncology 8 (1) (2024)
Li Sun, Wei Guo, Lei Guo, Xiaoxi Chen, Haitao Zhou, Shi Yan, Gang Zhao, Hua Bao, Xue Wu, Yang Shao, Jian-Ming Ying, Lin Lin
Molecular landscape and multi-omic measurements of heterogeneity in fetal adenocarcinoma of the lung. NPJ precision oncology 8 (1) (2024)
Wei Guo, Tan Wang, Qilin Huai, Lei Guo, Xiaobing Wang, Jie He
KIAA1429 regulates lung adenocarcinoma proliferation and metastasis through the PI3K/AKT pathway by modulating ARHGAP30 expression. Thoracic cancer (2024)
Bolun Zhou, Fan Zhang, Wei Guo, Shuhang Wang, Ning Li, Bin Qiu, Liang Zhao, Jian Li, Kang Shao, Qi Xue, Fang Lv, Shugeng Gao
Five-year follow-up of neoadjuvant PD-1 inhibitor (sintilimab) in non-small cell lung cancer. Journal for immunotherapy of cancer 12 (8) (2024)
Wei Guo, Tan Wang, Qilin Huai, Lei Guo, Xiaobing Wang, Jie He
KIAA1429 regulates lung adenocarcinoma proliferation and metastasis through the PI3K/AKT pathway by modulating ARHGAP30 expression. Thoracic cancer 15 (18) (2024)
Wei Guo, Tan Wang, Qilin Huai, Lei Guo, Xiaobing Wang, Jie He
KIAA1429 regulates lung adenocarcinoma proliferation and metastasis through the PI3K/AKT pathway by modulating ARHGAP30 expression. Thoracic cancer 15 (18) (2024)
Wei Guo, Tan Wang, Qilin Huai, Lei Guo, Xiaobing Wang, Jie He
KIAA1429 regulates lung adenocarcinoma proliferation and metastasis through the PI3K/AKT pathway by modulating ARHGAP30 expression. Thoracic cancer (2024)
Li Sun, Wei Guo, Lei Guo, Xiaoxi Chen, Haitao Zhou, Shi Yan, Gang Zhao, Hua Bao, Xue Wu, Yang Shao, Jian-Ming Ying, Lin Lin
Molecular landscape and multi-omic measurements of heterogeneity in fetal adenocarcinoma of the lung. NPJ precision oncology 8 (1) (2024)
Bolun Zhou, Fan Zhang, Wei Guo, Shuhang Wang, Ning Li, Bin Qiu, Liang Zhao, Jian Li, Kang Shao, Qi Xue, Fang Lv, Shugeng Gao
Five-year follow-up of neoadjuvant PD-1 inhibitor (sintilimab) in non-small cell lung cancer. Journal for immunotherapy of cancer 12 (8) (2024)
Qian Zhang, Xiuli Tao, Pei Yuan, Zewei Zhang, Jianming Ying, Lei Guo, Ning Li, Shuhang Wang, Jing Li, Ying Liu, Wei Guo, Shijun Zhao, Ning Wu
Predictive value of 18 F-FDG PET/CT and serum tumor markers for tumor mutational burden in patients with non-small cell lung cancer. Cancer medicine (2023)
Fenglong Bie, Zhijie Wang, Yulong Li, Wei Guo, Yuanyuan Hong, Tiancheng Han, Fang Lv, Shunli Yang, Suxing Li, Xi Li, Peiyao Nie, Shun Xu, Ruochuan Zang, Moyan Zhang, Peng Song, Feiyue Feng, Jianchun Duan, Guangyu Bai, Yuan Li, Qilin Huai, Bolun Zhou, Yu S Huang, Weizhi Chen, Feng-Wei Tan, Shugeng Gao
Multimodal analysis of cell-free DNA whole-methylome sequencing for cancer detection and localization. Nature communications 14 (1) (2023)
Wei Guo, Tao Zhang, Runze Li, Xiaoxi Chen, Jiaohui Pang, Hua Bao, Xue Wu, Yang Shao, Bin Qiu, Shugeng Gao, Jie He
Molecular risk factors for locoregional recurrence in resected non-small cell lung cancer. Cancer medicine (2023)
Qilin Huai, Chenyu Luo, Peng Song, Fenglong Bie, Guangyu Bai, Yuan Li, Yang Liu, Xiaowei Chen, Bolun Zhou, Xujie Sun, Wei Guo, Shugeng Gao
Peripheral blood inflammatory biomarkers dynamics reflect treatment response and predict prognosis in non-small cell lung cancer patients with neoadjuvant immunotherapy. Cancer science (2023)
Lei Guo, Qilin Huai, Bolun Zhou, Jianming Ying, Wei Guo
Comprehensive analysis of the prognostic impact and immune implication of KIAA1429 in lung adenocarcinoma. Cancer innovation 1 (4) (2022)
Renda Li, Zhenlin Yang, Fei Shao, Hong Cheng, Yaru Wen, Sijin Sun, Wei Guo, Zitong Li, Fan Zhang, Liyan Xue, Nan Bi, Jie Wang, Yingli Sun, Yin Li, Fengwei Tan, Qi Xue, Shugeng Gao, Susheng Shi, Yibo Gao, Jie He
Multi-omics profiling of primary small cell carcinoma of the esophagus reveals RB1 disruption and additional molecular subtypes. Nature communications 12 (1) (2021)
Zhenlin Yang, Yue Peng, Wei Guo, Jiachen Xu, Lin Li, He Tian, Renda Li, Lei Liu, Fengwei Tan, Shugeng Gao, Jie He
PD-L1 and CD47 co-expression predicts survival and enlightens future dual-targeting immunotherapy in non-small cell lung cancer. Thoracic cancer 12 (11) (2021)
Bin Qiu, Wei Guo, Fan Zhang, Fang Lv, Ying Ji, Yue Peng, Xiaoxi Chen, Hua Bao, Yang Xu, Yang W Shao, Fengwei Tan, Qi Xue, Shugeng Gao, Jie He
Dynamic recurrence risk and adjuvant chemotherapy benefit prediction by ctDNA in resected NSCLC. Nature communications 12 (1) (2021)
Sijin Sun, Wei Guo, Zhen Wang, Xin Wang, Guochao Zhang, Hao Zhang, Renda Li, Yibo Gao, Bin Qiu, Fengwei Tan, Yushun Gao, Qi Xue, Shugeng Gao, Jie He
Development and validation of an immune-related prognostic signature in lung adenocarcinoma. Cancer medicine 9 (16) (2020)
Hao Zhang, Fei Shao, Wei Guo, Yibo Gao, Jie He
Knockdown of KLF5 promotes cisplatin-induced cell apoptosis via regulating DNA damage checkpoint proteins in non-small cell lung cancer. Thoracic cancer 10 (5) (2019)

Wei Guo.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Wei Guo